Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1973 1
1974 1
1975 2
1976 3
1977 1
1978 4
1979 4
1980 5
1981 2
1982 3
1983 3
1984 4
1985 7
1986 3
1987 9
1988 7
1989 8
1990 4
1991 9
1992 9
1993 14
1994 11
1995 9
1996 10
1997 8
1998 17
1999 13
2000 10
2001 12
2002 10
2003 16
2004 26
2005 16
2006 17
2007 20
2008 16
2009 18
2010 17
2011 20
2012 23
2013 21
2014 29
2015 30
2016 27
2017 26
2018 26
2019 18
2020 26
2021 34
2022 36
2023 35
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

650 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Parathyroid Gland Carcinoma"
Page 1
Parathyroid carcinoma.
Goswamy J, Lei M, Simo R. Goswamy J, et al. Curr Opin Otolaryngol Head Neck Surg. 2016 Apr;24(2):155-62. doi: 10.1097/MOO.0000000000000234. Curr Opin Otolaryngol Head Neck Surg. 2016. PMID: 26771263 Review.
PURPOSE OF REVIEW: This article highlights recent advances in our understanding of the incidence, epidemiology, clinical presentation, evaluation, diagnosis, treatment, and prognosis of parathyroid carcinoma. RECENT FINDINGS: The prevalence of parathyroid …
PURPOSE OF REVIEW: This article highlights recent advances in our understanding of the incidence, epidemiology, clinical presentation, evalu …
Surgery for primary hyperparathyroidism.
das Neves MC, Santos RO, Ohe MN. das Neves MC, et al. Arch Endocrinol Metab. 2022 Nov 11;66(5):678-688. doi: 10.20945/2359-3997000000557. Arch Endocrinol Metab. 2022. PMID: 36382757 Free PMC article. Review.
Primary hyperparathyroidism (PHPT) is a hypercalcemic disorder that occurs when one or more parathyroid glands produces excessive parathyroid hormone (PTH). PHPT is typically treated with surgery, and it remains the only definitive therapy, whose techniques have evo …
Primary hyperparathyroidism (PHPT) is a hypercalcemic disorder that occurs when one or more parathyroid glands produces excessive …
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL, Gandhi A, Scott-Coombes D, Perros P. Mitchell AL, et al. J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578. J Laryngol Otol. 2016. PMID: 27841128 Free PMC article.
(R) Post-therapy dynamic risk stratification at 9-12 months is used to guide further management. (G) Potentially resectable recurrent or persistent disease should be managed with surgery whenever possible. ...(R) Chemotherapy with tyrosine kinase inhibitors may help in con …
(R) Post-therapy dynamic risk stratification at 9-12 months is used to guide further management. (G) Potentially resectable recurrent …
Persistent and recurrent hyperparathyroidism.
Guerin C, Paladino NC, Lowery A, Castinetti F, Taieb D, Sebag F. Guerin C, et al. Updates Surg. 2017 Jun;69(2):161-169. doi: 10.1007/s13304-017-0447-7. Epub 2017 Apr 22. Updates Surg. 2017. PMID: 28434176 Review.
The aim of this review is to expose the management of persistent and recurrent hyperparathyroidism. A literature search was performed on MEDLINE using the search terms "recurrent" or "persistent" and "hyperparathyroidism" within the past 10 years. ...A single adenom …
The aim of this review is to expose the management of persistent and recurrent hyperparathyroidism. A literature search was performed …
Parathyroid carcinoma: Single centre experience.
Cunha C, Pinheiro SL, Donato S, Tavares Bello C, Simões H, Nunes Silva T, Prazeres S, Doutel D, Cavaco BM, Leite V. Cunha C, et al. Clin Endocrinol (Oxf). 2022 Sep;97(3):250-257. doi: 10.1111/cen.14684. Epub 2022 Feb 9. Clin Endocrinol (Oxf). 2022. PMID: 35120263
OBJECTIVE: Parathyroid Carcinoma is a rare malignant neoplasm, accounting for less than 1% of primary hyperparathyroidism cases. ...CDC73 mutations were present in 38.5% of analysed patients and one patient was diagnosed with MEN1. CONCLUSION: Parathyroid …
OBJECTIVE: Parathyroid Carcinoma is a rare malignant neoplasm, accounting for less than 1% of primary hyperparathyroidism case …
Approach to the Patient With Parathyroid Carcinoma.
Cetani F, Pardi E, Torregrossa L, Borsari S, Pierotti L, Dinoi E, Marcocci C. Cetani F, et al. J Clin Endocrinol Metab. 2023 Dec 21;109(1):256-268. doi: 10.1210/clinem/dgad455. J Clin Endocrinol Metab. 2023. PMID: 37531615
Parathyroid carcinoma (PC) is usually associated with severe symptomatic primary hyperparathyroidism (PHPT) and accounts for less than 1% of all cases of PHPT and approximately 0.005% of all cancers. ...En bloc resection of the tumor, together with the ipsilateral t …
Parathyroid carcinoma (PC) is usually associated with severe symptomatic primary hyperparathyroidism (PHPT) and accounts for l …
Parathyroid carcinoma: Challenges in diagnosis and treatment.
Betea D, Potorac I, Beckers A. Betea D, et al. Ann Endocrinol (Paris). 2015 May;76(2):169-77. doi: 10.1016/j.ando.2015.03.003. Epub 2015 Apr 21. Ann Endocrinol (Paris). 2015. PMID: 25910997 Review.
Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering from primary hyperparathyroidism. This cancer continues to cause challenges for diagnosis and treatment because of its rarity, overlapping features with benign parathyro …
Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering from primary hyperparathyroidism …
Molecular and Clinical Spectrum of Primary Hyperparathyroidism.
Jha S, Simonds WF. Jha S, et al. Endocr Rev. 2023 Sep 15;44(5):779-818. doi: 10.1210/endrev/bnad009. Endocr Rev. 2023. PMID: 36961765 Free PMC article.
Genetic testing for heritable forms should be offered to patients with multiglandular disease, recurrent PHPT, young onset PHPT (age 40 years), and those with a family history of parathyroid tumors. ...Furthermore, there is no systemic therapy for parathyroid …
Genetic testing for heritable forms should be offered to patients with multiglandular disease, recurrent PHPT, young onset PHPT (age …
Parathyroid carcinoma: etiology, diagnosis, and treatment.
Okamoto T, Iihara M, Obara T, Tsukada T. Okamoto T, et al. World J Surg. 2009 Nov;33(11):2343-54. doi: 10.1007/s00268-009-9999-0. World J Surg. 2009. PMID: 19350316 Review.
BACKGROUND: The goal of the present study was to make our medical practice evidence-based for patients with parathyroid carcinoma. METHODS: We posed six clinical questions relevant to the management of parathyroid cancer. ...Severe hypercalcemia and its relat …
BACKGROUND: The goal of the present study was to make our medical practice evidence-based for patients with parathyroid carcinoma …
Follicular cell-derived thyroid cancer.
Dralle H, Machens A, Basa J, Fatourechi V, Franceschi S, Hay ID, Nikiforov YE, Pacini F, Pasieka JL, Sherman SI. Dralle H, et al. Nat Rev Dis Primers. 2015 Dec 10;1:15077. doi: 10.1038/nrdp.2015.77. Nat Rev Dis Primers. 2015. PMID: 27188261 Review.
In thyroid cancer surgery, for instance, injuries to structures outside the thyroid gland, such as the recurrent laryngeal nerve in 2-5% of surgeries or the parathyroid glands in 5-10% of surgeries, negatively affect quality of life more than loss of the expe …
In thyroid cancer surgery, for instance, injuries to structures outside the thyroid gland, such as the recurrent laryngeal ner …
650 results